APA (7th ed.) Citation

G, C., SG, K., CW, N., CM, R., SM, P., S, N., . . . MM, K. (2020). Efficacy of osimertinib against EGFRvIII+ glioblastoma. Oncotarget, 11(22), 2074. https://doi.org/10.18632/oncotarget.27599

Chicago Style (17th ed.) Citation

G, Chagoya, et al. "Efficacy of Osimertinib Against EGFRvIII+ Glioblastoma." Oncotarget 11, no. 22 (2020): 2074. https://doi.org/10.18632/oncotarget.27599.

MLA (9th ed.) Citation

G, Chagoya, et al. "Efficacy of Osimertinib Against EGFRvIII+ Glioblastoma." Oncotarget, vol. 11, no. 22, 2020, p. 2074, https://doi.org/10.18632/oncotarget.27599.